(Q48413276)

English

Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD).

scientific article published on 10 August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22883353

Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD). (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22883353

major depressive disorder

1 reference

based on heuristic

inferred from title

Wakako Umene-Nakano

5

object named as

Wakako Umene-Nakano

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22883353

Reiji Yoshimura

2

object named as

Reiji Yoshimura

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22883353

10

object named as

Jun Nakamura

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22883353

Atsuko Ikenouchi-Sugita

6

object named as

Atsuko Ikenouchi-Sugita

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22883353

9

object named as

Nakao Iwata

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22883353

4

object named as

Hikaru Hori

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22883353

1

object named as

Asuka Katsuki

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22883353

8

object named as

Kiyokazu Atake

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22883353

3

object named as

Taro Kishi

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22883353

author name string

Kenji Hayashi

7

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22883353

publication date

10 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22883353

number of pages

9

1 reference

based on heuristic

inferred from page(s)

C N S Spectrums

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22883353

17

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22883353

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22883353

155-163

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22883353

Does bereavement-related major depression differ from major depression associated with other stressful life events?

1 reference

https://api.crossref.org/works/10.1017%2FS109285291200051X

21 January 2018

The effect of depression, BDNF gene val66met polymorphism and gender on serum BDNF levels.

1 reference

https://api.crossref.org/works/10.1017%2FS109285291200051X

21 January 2018

Brain derived neurotrophic factor gene polymorphism (Val66Met) and short-term antidepressant response in major depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS109285291200051X

21 January 2018

Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients

1 reference

https://api.crossref.org/works/10.1017%2FS109285291200051X

21 January 2018

Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS109285291200051X

21 January 2018

Serum BDNF levels before treatment predict SSRI response in depression

1 reference

https://api.crossref.org/works/10.1017%2FS109285291200051X

21 January 2018

Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphism

1 reference

https://api.crossref.org/works/10.1017%2FS109285291200051X

21 January 2018

Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications

1 reference

https://api.crossref.org/works/10.1017%2FS109285291200051X

21 January 2018

Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients.

1 reference

https://api.crossref.org/works/10.1017%2FS109285291200051X

21 January 2018

Brain-derived neurotrophic factor gene polymorphisms and mirtazapine responses in Koreans with major depression.

1 reference

https://api.crossref.org/works/10.1017%2FS109285291200051X

21 January 2018

The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study

1 reference

https://api.crossref.org/works/10.1017%2FS109285291200051X

21 January 2018

Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants

1 reference

https://api.crossref.org/works/10.1017%2FS109285291200051X

21 January 2018

Serum and plasma BDNF levels in major depression: a replication study and meta-analyses.

1 reference

https://api.crossref.org/works/10.1017%2FS109285291200051X

21 January 2018

Decreased serum brain-derived neurotrophic factor levels in major depressed patients.

1 reference

https://api.crossref.org/works/10.1017%2FS109285291200051X

21 January 2018

A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression

1 reference

https://api.crossref.org/works/10.1017%2FS109285291200051X

21 January 2018

A molecular and cellular theory of depression

1 reference

https://api.crossref.org/works/10.1017%2FS109285291200051X

21 January 2018

The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients.

1 reference

https://api.crossref.org/works/10.1017%2FS109285291200051X

21 January 2018

Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex

1 reference

https://api.crossref.org/works/10.1017%2FS109285291200051X

21 January 2018

Chronic antidepressant administration alleviates frontal and hippocampal BDNF deficits in CUMS rat.

1 reference

https://api.crossref.org/works/10.1017%2FS109285291200051X

21 January 2018

Serum brain-derived neurotrophic factor level in relation to illness severity and episode duration in patients with major depression

1 reference

https://api.crossref.org/works/10.1017%2FS109285291200051X

21 January 2018

Correlations between brain-derived neurotrophic factor and clinical symptoms in medicated patients with major depression.

1 reference

https://api.crossref.org/works/10.1017%2FS109285291200051X

21 January 2018

Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients.

1 reference

https://api.crossref.org/works/10.1017%2FS109285291200051X

21 January 2018

Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression.

1 reference

https://api.crossref.org/works/10.1017%2FS109285291200051X

21 January 2018

Sequential catecholamine and serotonin depletion in mirtazapine-treated depressed patients.

1 reference

https://api.crossref.org/works/10.1017%2FS109285291200051X

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of free 3-methoxy-4-hydroxyphenylglycol with several other monoamine metabolites in plasma by high-performance liquid chromatography with amperometric detection

1 reference

https://api.crossref.org/works/10.1017%2FS109285291200051X

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of 3,4-dihydroxyphenylacetic acid and 5-hydroxyindoleacetic acid in human plasma by a simple and rapid high-performance liquid chromatography assay

1 reference

https://api.crossref.org/works/10.1017%2FS109285291200051X

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission

1 reference

https://api.crossref.org/works/10.1017%2FS109285291200051X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S109285291200051X

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22883353

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/22883353

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48413276&oldid=1765290449"